• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Focus on the Alzheimer's and Parkinson's Disease Drugs Market: Drug Classification, Future Therapies and Key Players

Posted on: Thursday, 27 September 2007, 06:00 CDT

Reportlinker.com announces that a new market research report related to the worldwide pharmaceutical industry is now available to its catalogue.

Alzheimer's and Parkinson's Disease

www.reportlinker.com/p059672/Alzheimer-Parkinson-Disease.html

This report analyzes the worldwide markets for Alzheimer's and Parkinson's Disease in Millions of US$.

The Major product segments Analyzed are Anti-Alzheimer's Disease Drugs (Cholinesterase Inhibitors, & NMDARA), and Anti-Parkinson's Disease Drugs (Dopaminergic Agents, Dopamine Agonists, & Other PD Drugs (Include COMT Inhibitors, MOA-B Inhibitors, and Dopamine Amplifiers).

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2010.

The report profiles 87 companies including many key and niche players worldwide such as Boehringer Ingelheim, Bristol-Myers Squibb Co., Eisai Inc., Eli Lilly and Company, Forest Pharmaceuticals, GlaxoSmithKline PLC, H. Lundbeck A/S, Merz Pharmaceuticals GMBH, Novartis AG, Ortho-McNeil Neurologics, Inc., Pfizer Inc., Roche, Shire Pharmaceuticals PLC, and Valeant Pharmaceuticals International.

Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Table of content

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. Outlook

2. Neurodegenerative Diseases Market - A Brief Overview

3. Alzheimer's Market Overview

4. Parkinson's Disease Market Overview

5. Disease Overview

6. Drug Classification

7. Future Therapies

8. New Findings

9. Recent Industry Activity

10. Focus on Select Players

11. Global Market Perspective

III. MARKET

1. The United States

2. Canada

3. Japan

4. Europe

4a. Germany

4b. France

4c. United Kingdom

4d. Italy

4e. Spain

4f. Rest of Europe

5. Rest of World

IV. COMPETITION

1. Acumen Pharmaceuticals Inc. (USA)

2. Amarin Corporation PLC (UK)

3. Amorfix Life Sciences Ltd. (Canada)

4. Apotex, Inc. (Canada)

5. Asterand PLC (UK)

6. Avicena Group, Inc. (USA)

7. Avigen, Inc. (USA)

8. Axonyx, Inc. (USA)

9. Boehringer Ingelheim GmbH (Germany)

10. Brainstorm Cell Therapeutics, Inc. (USA)

11. Bristol-Myers Squibb Company (USA)

12. Britannia Pharmaceuticals Ltd. (UK)

13. CeNeS Pharmaceuticals PLC (England)

14. Cephalon, Inc. (USA)

15. Ceregene, Inc. (USA)

16. CoMentis, Inc. (USA)

17. Comtan (USA)

18. Desitin Arzneimittel GmbH (Germany)

19. Digilab, Inc. (USA)

20. Draxis Health, Inc. (Canada)

21. Eisai Co., Ltd. (Japan)

22. Eli Lilly and Company (USA)

23. Epix Pharmaceuticals (USA)

24. Ester Neurosciences Ltd. (Israel)

25. Evotec AG (Germany)

26. Exelon (USA)

27. F. Hoffmann-La Roche Ltd. (Switzerland)

28. Forest Laboratories, Inc. (USA)

29. Gedeon Richter Ltd. (Hungary)

30. Gerolymatos P. N., SA (Greece)

31. GlaxoSmithKline PLC (UK)

32. H. Lundbeck AS (Denmark)

33. Idera Pharmaceuticals, Inc.(USA)

34. Immuno-Biological Laboratories Co. Ltd. (Japan)

35. Impax Laboratories, Inc. (USA)

36. Intellect Neurosciences Inc. (USA)

37. Intrexon Corporation (USA)

38. Johnson & Johnson (USA)

39. Kyowa Hakko Kogyo Co., Ltd. (Japan)

40. Medtronic, Inc. (USA)

41. Merck KGaA (Germany)

42. Merz Pharmaceuticals GmbH (Germany)

43. Mirapex (USA)

44. Myriad Genetics, Inc. (USA)

45. Neuren Pharmaceuticals Limited (New Zealand)

46. Neurim Pharmaceuticals Ltd. (Israel)

47. Neurochem, Inc. (Canada)

48. Neurogen Corporation (USA)

49. Neuro-Hitech, Inc. (USA)

50. Neurologix, Inc. (USA)

51. Neuropharma, S.A. (Spain)

52. Neuroptix Corporation (USA)

53. Newron Pharmaceuticals SpA (Italy)

54. Novartis AG (Switzerland)

55. NsGene A/S (Denmark)

56. Nymox Pharmaceutical Corporation (Canada)

57. Orion Corporation (Finland)

58. Ortho-McNeil Neurologics, Inc. (USA)

59. Pfizer, Inc. (USA)

60. Pharmacopeia Drug Discovery, Inc. (USA)

61. Prana Biotechnology Limited (Australia)

62. Ranbaxy Pharmaceuticals, Inc. (USA)

63. ReGen Therapeutics PLC (UK)

64. ReNeuron Ltd. (UK)

65. Samaritan Pharmaceuticals, Inc. (USA)

66. Sanofi-Aventis (France)

67. Schering España SA (Spain)

68. Schwarz Pharma AG (Germany)

69. Sciele Pharma, Inc. (USA)

70. Senexis Limited (UK)

71. Shire Pharmaceuticals Group PLC (UK)

72. Siemens Medical Solutions (USA)

73. Somerset Pharmaceuticals, Inc. (USA)

74. Stalevo (USA)

75. Terapia Ranbaxy (Romania)

76. Teva Pharmaceutical Industries Ltd. (Israel)

77. Titan Pharmaceuticals, Inc. (USA)

78. TorreyPines Therapeutics (USA)

79. Transition Therapeutics, Inc. (USA)

80. Tripos, Inc. (USA)

81. Unipharm Ltd. (Israel)

82. Valeant Pharmaceuticals International (USA)

83. Vernalis PLC (UK)

84. Voyager Pharmaceutical Corporation (USA)

85. Wyeth (USA)

86. Zentiva, A.S. (Czech Republic)

87. Zhejiang Yixin Pharmaceutical Company Limited (China)

More market research reports? Go to http://www.reportlinker.com

http://www.reportlinker.com/ci0232/Neurology-market-research.html

http://agribusinessmarket.wordpress.com

Source: Business Wire

More News in this Category